内皮機能障害:治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Endothelial Dysfunction Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Endothelial Dysfunction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Endothelial Dysfunction to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Endothelial Dysfunction 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Endothelial Dysfunction Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Nestle S.A. 37
Clinical Trial Overview of Nestle S.A. 37
BioMarin Pharmaceutical Inc. 38
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 38
Han Wha Pharma Co., Ltd. 39
Clinical Trial Overview of Han Wha Pharma Co., Ltd. 39
C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 40
Clinical Trial Overview of Top Institutes / Government 41
National Defense Medical College 41
Clinical Trial Overview of National Defense Medical College 41
Radboud University 42
Clinical Trial Overview of Radboud University 42
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 43
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 43
University of California, San Francisco 44
Clinical Trial Overview of University of California, San Francisco 44
Boston University 45
Clinical Trial Overview of Boston University 45
Emory University 46
Clinical Trial Overview of Emory University 46
Mayo Clinic 47
Clinical Trial Overview of Mayo Clinic 47
Wageningen University 48
Clinical Trial Overview of Wageningen University 48
Vanderbilt University 49
Clinical Trial Overview of Vanderbilt University 49
Wuhan General Hospital of Guangzhou Military Command 50
Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command 50
Five Key Clinical Profiles 51
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76


【レポート販売概要】

■ タイトル:内皮機能障害:治療薬のグローバル治験動向(2014年下半期)
■ 英文:Endothelial Dysfunction Global Clinical Trials Review, H2, 2014
■ 発行日:2014年9月10日
■ 調査会社:GlobalData
■ 商品コード:GDHC2329CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。